TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...

Barclays analyst Luke Sergott raised the firm’s price target on Avantor (AVTR) to $26 from $25 and keeps an Overweight rating on the shares.

In a report released today, Luke Sergott from Barclays maintained a Buy rating on Avantor (AVTR – Research Report), with a price target of ...

TriLink BioTechnologies, a Maravai LifeSciences company and provider of life science reagents and services, has partnered ...

Wall Street expects flat earnings compared to the year-ago quarter on lower revenues when Avantor, Inc. (AVTR) reports results for the quarter ended December 2024. While this widely-known consensus ...

RADNOR, PA — Avantor, Inc. (NYSE: AVTR) has announced a definitive agreement to sell its clinical services business to Audax ...

Avantor Inc (AVTR) stock saw a modest uptick, ending the day at $22.06 which represents a slight increase of $0.19 or 0.87% from the prior close of $21.87. The stock opened at $21.96 and touched a low ...

UBS has recently reduced Avantor Inc (AVTR) stock to Neutral rating, as announced on January 17, 2025, according to Finviz. Earlier, on August 28, 2024, Wells Fargo had initiated the stock to ...

Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. Its portfolio includes ...

Get Our Latest Research Report on Avantor Avantor Trading Down 3.9 % Shares of AVTR stock opened at $21.55 on Thursday. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to ...

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release ...